Global Urological Cancer Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
Urologic cancers include cancers of the bladder, kidney, prostate and testicles, all relatively common. Prostate cancer, for example, is the most common cancer in American men. One out of every 10 men will develop the disease at some time in his life — most often after age 50.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Urological Cancer Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Urological Cancer Drugs market are covered in Chapter 9:
Celgene Corporation
GlaxoSmithKline
Roche Healthcare
Ipsen
Ferring Pharmaceuticals
Abbott Laboratories
Indevus Pharmaceuticals Inc
Pfizer
Dendreon Corporation
Sanofi S.A.
AstraZeneca
Astellas
Novartis
Tolmar Inc
Johnson & Johnson
Bristol-Myers Squibb
In Chapter 5 and Chapter 7.3, based on types, the Urological Cancer Drugs market from 2017 to 2027 is primarily split into:
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
In Chapter 6 and Chapter 7.4, based on applications, the Urological Cancer Drugs market from 2017 to 2027 covers:
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Urological Cancer Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Urological Cancer Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 UROLOGICAL CANCER DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Urological Cancer Drugs Market
1.2 Urological Cancer Drugs Market Segment by Type
1.2.1 Global Urological Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Urological Cancer Drugs Market Segment by Application
1.3.1 Urological Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Urological Cancer Drugs Market, Region Wise (2017-2027)
1.4.1 Global Urological Cancer Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.4 China Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.6 India Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Urological Cancer Drugs (2017-2027)
1.5.1 Global Urological Cancer Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Urological Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Urological Cancer Drugs Market
2 INDUSTRY OUTLOOK
2.1 Urological Cancer Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Urological Cancer Drugs Market Drivers Analysis
2.4 Urological Cancer Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Urological Cancer Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Urological Cancer Drugs Industry Development
3 GLOBAL UROLOGICAL CANCER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Urological Cancer Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Urological Cancer Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Urological Cancer Drugs Average Price by Player (2017-2022)
3.4 Global Urological Cancer Drugs Gross Margin by Player (2017-2022)
3.5 Urological Cancer Drugs Market Competitive Situation and Trends
3.5.1 Urological Cancer Drugs Market Concentration Rate
3.5.2 Urological Cancer Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL UROLOGICAL CANCER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Urological Cancer Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Urological Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Urological Cancer Drugs Market Under COVID-19
4.5 Europe Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Urological Cancer Drugs Market Under COVID-19
4.6 China Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Urological Cancer Drugs Market Under COVID-19
4.7 Japan Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Urological Cancer Drugs Market Under COVID-19
4.8 India Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Urological Cancer Drugs Market Under COVID-19
4.9 Southeast Asia Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Urological Cancer Drugs Market Under COVID-19
4.10 Latin America Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Urological Cancer Drugs Market Under COVID-19
4.11 Middle East and Africa Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Urological Cancer Drugs Market Under COVID-19
5 GLOBAL UROLOGICAL CANCER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Urological Cancer Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Urological Cancer Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Urological Cancer Drugs Price by Type (2017-2022)
5.4 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
5.4.2 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
5.4.3 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Inlyta (Axitinib) (2017-2022)
5.4.4 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
5.4.5 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
5.4.6 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
5.4.7 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
5.4.8 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Opdivo (Nivolumab) (2017-2022)
5.4.9 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
6 GLOBAL UROLOGICAL CANCER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Urological Cancer Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Urological Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Urological Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Urological Cancer Drugs Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.2 Global Urological Cancer Drugs Consumption and Growth Rate of Bladder Cancer (2017-2022)
6.3.3 Global Urological Cancer Drugs Consumption and Growth Rate of Kidney Cancer (2017-2022)
6.3.4 Global Urological Cancer Drugs Consumption and Growth Rate of Testicular Cancer (2017-2022)
7 GLOBAL UROLOGICAL CANCER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Urological Cancer Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Urological Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Urological Cancer Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Urological Cancer Drugs Price and Trend Forecast (2022-2027)
7.2 Global Urological Cancer Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Urological Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Urological Cancer Drugs Revenue and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
7.3.2 Global Urological Cancer Drugs Revenue and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
7.3.3 Global Urological Cancer Drugs Revenue and Growth Rate of Inlyta (Axitinib) (2022-2027)
7.3.4 Global Urological Cancer Drugs Revenue and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
7.3.5 Global Urological Cancer Drugs Revenue and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
7.3.6 Global Urological Cancer Drugs Revenue and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
7.3.7 Global Urological Cancer Drugs Revenue and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
7.3.8 Global Urological Cancer Drugs Revenue and Growth Rate of Opdivo (Nivolumab) (2022-2027)
7.3.9 Global Urological Cancer Drugs Revenue and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
7.4 Global Urological Cancer Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Urological Cancer Drugs Consumption Value and Growth Rate of Prostate Cancer(2022-2027)
7.4.2 Global Urological Cancer Drugs Consumption Value and Growth Rate of Bladder Cancer(2022-2027)
7.4.3 Global Urological Cancer Drugs Consumption Value and Growth Rate of Kidney Cancer(2022-2027)
7.4.4 Global Urological Cancer Drugs Consumption Value and Growth Rate of Testicular Cancer(2022-2027)
7.5 Urological Cancer Drugs Market Forecast Under COVID-19
8 UROLOGICAL CANCER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Urological Cancer Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Urological Cancer Drugs Analysis
8.6 Major Downstream Buyers of Urological Cancer Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Urological Cancer Drugs Industry
9 PLAYERS PROFILES
9.1 Celgene Corporation
9.1.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.1.3 Celgene Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.2.3 GlaxoSmithKline Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Roche Healthcare
9.3.1 Roche Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.3.3 Roche Healthcare Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Ipsen
9.4.1 Ipsen Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.4.3 Ipsen Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Ferring Pharmaceuticals
9.5.1 Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.5.3 Ferring Pharmaceuticals Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.6.3 Abbott Laboratories Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Indevus Pharmaceuticals Inc
9.7.1 Indevus Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.7.3 Indevus Pharmaceuticals Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer
9.8.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.8.3 Pfizer Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Dendreon Corporation
9.9.1 Dendreon Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.9.3 Dendreon Corporation Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Sanofi S.A.
9.10.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.10.3 Sanofi S.A. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca
9.11.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.11.3 AstraZeneca Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Astellas
9.12.1 Astellas Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.12.3 Astellas Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis
9.13.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.13.3 Novartis Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Tolmar Inc
9.14.1 Tolmar Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.14.3 Tolmar Inc Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Johnson & Johnson
9.15.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.15.3 Johnson & Johnson Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Bristol-Myers Squibb
9.16.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.16.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Urological Cancer Drugs Market
1.2 Urological Cancer Drugs Market Segment by Type
1.2.1 Global Urological Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Urological Cancer Drugs Market Segment by Application
1.3.1 Urological Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Urological Cancer Drugs Market, Region Wise (2017-2027)
1.4.1 Global Urological Cancer Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.4 China Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.6 India Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Urological Cancer Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Urological Cancer Drugs (2017-2027)
1.5.1 Global Urological Cancer Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Urological Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Urological Cancer Drugs Market
2 INDUSTRY OUTLOOK
2.1 Urological Cancer Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Urological Cancer Drugs Market Drivers Analysis
2.4 Urological Cancer Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Urological Cancer Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Urological Cancer Drugs Industry Development
3 GLOBAL UROLOGICAL CANCER DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Urological Cancer Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Urological Cancer Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Urological Cancer Drugs Average Price by Player (2017-2022)
3.4 Global Urological Cancer Drugs Gross Margin by Player (2017-2022)
3.5 Urological Cancer Drugs Market Competitive Situation and Trends
3.5.1 Urological Cancer Drugs Market Concentration Rate
3.5.2 Urological Cancer Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL UROLOGICAL CANCER DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Urological Cancer Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Urological Cancer Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Urological Cancer Drugs Market Under COVID-19
4.5 Europe Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Urological Cancer Drugs Market Under COVID-19
4.6 China Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Urological Cancer Drugs Market Under COVID-19
4.7 Japan Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Urological Cancer Drugs Market Under COVID-19
4.8 India Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Urological Cancer Drugs Market Under COVID-19
4.9 Southeast Asia Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Urological Cancer Drugs Market Under COVID-19
4.10 Latin America Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Urological Cancer Drugs Market Under COVID-19
4.11 Middle East and Africa Urological Cancer Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Urological Cancer Drugs Market Under COVID-19
5 GLOBAL UROLOGICAL CANCER DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Urological Cancer Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Urological Cancer Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Urological Cancer Drugs Price by Type (2017-2022)
5.4 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
5.4.2 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
5.4.3 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Inlyta (Axitinib) (2017-2022)
5.4.4 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
5.4.5 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
5.4.6 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
5.4.7 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
5.4.8 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Opdivo (Nivolumab) (2017-2022)
5.4.9 Global Urological Cancer Drugs Sales Volume, Revenue and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
6 GLOBAL UROLOGICAL CANCER DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Urological Cancer Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Urological Cancer Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Urological Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Urological Cancer Drugs Consumption and Growth Rate of Prostate Cancer (2017-2022)
6.3.2 Global Urological Cancer Drugs Consumption and Growth Rate of Bladder Cancer (2017-2022)
6.3.3 Global Urological Cancer Drugs Consumption and Growth Rate of Kidney Cancer (2017-2022)
6.3.4 Global Urological Cancer Drugs Consumption and Growth Rate of Testicular Cancer (2017-2022)
7 GLOBAL UROLOGICAL CANCER DRUGS MARKET FORECAST (2022-2027)
7.1 Global Urological Cancer Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Urological Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Urological Cancer Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Urological Cancer Drugs Price and Trend Forecast (2022-2027)
7.2 Global Urological Cancer Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Urological Cancer Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Urological Cancer Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Urological Cancer Drugs Revenue and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
7.3.2 Global Urological Cancer Drugs Revenue and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
7.3.3 Global Urological Cancer Drugs Revenue and Growth Rate of Inlyta (Axitinib) (2022-2027)
7.3.4 Global Urological Cancer Drugs Revenue and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
7.3.5 Global Urological Cancer Drugs Revenue and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
7.3.6 Global Urological Cancer Drugs Revenue and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
7.3.7 Global Urological Cancer Drugs Revenue and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
7.3.8 Global Urological Cancer Drugs Revenue and Growth Rate of Opdivo (Nivolumab) (2022-2027)
7.3.9 Global Urological Cancer Drugs Revenue and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
7.4 Global Urological Cancer Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Urological Cancer Drugs Consumption Value and Growth Rate of Prostate Cancer(2022-2027)
7.4.2 Global Urological Cancer Drugs Consumption Value and Growth Rate of Bladder Cancer(2022-2027)
7.4.3 Global Urological Cancer Drugs Consumption Value and Growth Rate of Kidney Cancer(2022-2027)
7.4.4 Global Urological Cancer Drugs Consumption Value and Growth Rate of Testicular Cancer(2022-2027)
7.5 Urological Cancer Drugs Market Forecast Under COVID-19
8 UROLOGICAL CANCER DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Urological Cancer Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Urological Cancer Drugs Analysis
8.6 Major Downstream Buyers of Urological Cancer Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Urological Cancer Drugs Industry
9 PLAYERS PROFILES
9.1 Celgene Corporation
9.1.1 Celgene Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.1.3 Celgene Corporation Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.2.3 GlaxoSmithKline Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Roche Healthcare
9.3.1 Roche Healthcare Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.3.3 Roche Healthcare Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Ipsen
9.4.1 Ipsen Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.4.3 Ipsen Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 Ferring Pharmaceuticals
9.5.1 Ferring Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.5.3 Ferring Pharmaceuticals Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Abbott Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.6.3 Abbott Laboratories Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Indevus Pharmaceuticals Inc
9.7.1 Indevus Pharmaceuticals Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.7.3 Indevus Pharmaceuticals Inc Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Pfizer
9.8.1 Pfizer Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.8.3 Pfizer Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Dendreon Corporation
9.9.1 Dendreon Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.9.3 Dendreon Corporation Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Sanofi S.A.
9.10.1 Sanofi S.A. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.10.3 Sanofi S.A. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 AstraZeneca
9.11.1 AstraZeneca Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.11.3 AstraZeneca Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Astellas
9.12.1 Astellas Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.12.3 Astellas Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Novartis
9.13.1 Novartis Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.13.3 Novartis Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 Tolmar Inc
9.14.1 Tolmar Inc Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.14.3 Tolmar Inc Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Johnson & Johnson
9.15.1 Johnson & Johnson Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.15.3 Johnson & Johnson Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Bristol-Myers Squibb
9.16.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Urological Cancer Drugs Product Profiles, Application and Specification
9.16.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Urological Cancer Drugs Product Picture
Table Global Urological Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Urological Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Urological Cancer Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Urological Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Urological Cancer Drugs Industry Development
Table Global Urological Cancer Drugs Sales Volume by Player (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Share by Player (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Share by Player in 2021
Table Urological Cancer Drugs Revenue (Million USD) by Player (2017-2022)
Table Urological Cancer Drugs Revenue Market Share by Player (2017-2022)
Table Urological Cancer Drugs Price by Player (2017-2022)
Table Urological Cancer Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Urological Cancer Drugs Sales Volume, Region Wise (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Urological Cancer Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Urological Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share, Region Wise in 2021
Table Global Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Urological Cancer Drugs Sales Volume by Type (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share by Type in 2021
Table Global Urological Cancer Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Urological Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share by Type in 2021
Table Urological Cancer Drugs Price by Type (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Inlyta (Axitinib) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Opdivo (Nivolumab) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
Table Global Urological Cancer Drugs Consumption by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Market Share by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Prostate Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Bladder Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Kidney Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Testicular Cancer (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Urological Cancer Drugs Price and Trend Forecast (2022-2027)
Figure USA Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Urological Cancer Drugs Market Sales Volume Forecast, by Type
Table Global Urological Cancer Drugs Sales Volume Market Share Forecast, by Type
Table Global Urological Cancer Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Urological Cancer Drugs Revenue Market Share Forecast, by Type
Table Global Urological Cancer Drugs Price Forecast, by Type
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
Table Global Urological Cancer Drugs Market Consumption Forecast, by Application
Table Global Urological Cancer Drugs Consumption Market Share Forecast, by Application
Table Global Urological Cancer Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Urological Cancer Drugs Revenue Market Share Forecast, by Application
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Testicular Cancer (2022-2027)
Figure Urological Cancer Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Celgene Corporation Profile
Table Celgene Corporation Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Urological Cancer Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Urological Cancer Drugs Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Roche Healthcare Profile
Table Roche Healthcare Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Healthcare Urological Cancer Drugs Sales Volume and Growth Rate
Figure Roche Healthcare Revenue (Million USD) Market Share 2017-2022
Table Ipsen Profile
Table Ipsen Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ipsen Urological Cancer Drugs Sales Volume and Growth Rate
Figure Ipsen Revenue (Million USD) Market Share 2017-2022
Table Ferring Pharmaceuticals Profile
Table Ferring Pharmaceuticals Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ferring Pharmaceuticals Urological Cancer Drugs Sales Volume and Growth Rate
Figure Ferring Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Abbott Laboratories Profile
Table Abbott Laboratories Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Urological Cancer Drugs Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Indevus Pharmaceuticals Inc Profile
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales Volume and Growth Rate
Figure Indevus Pharmaceuticals Inc Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Urological Cancer Drugs Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Dendreon Corporation Profile
Table Dendreon Corporation Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dendreon Corporation Urological Cancer Drugs Sales Volume and Growth Rate
Figure Dendreon Corporation Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Urological Cancer Drugs Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Urological Cancer Drugs Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Astellas Profile
Table Astellas Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Urological Cancer Drugs Sales Volume and Growth Rate
Figure Astellas Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Urological Cancer Drugs Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Tolmar Inc Profile
Table Tolmar Inc Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Tolmar Inc Urological Cancer Drugs Sales Volume and Growth Rate
Figure Tolmar Inc Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Urological Cancer Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Urological Cancer Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Figure Urological Cancer Drugs Product Picture
Table Global Urological Cancer Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Urological Cancer Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Urological Cancer Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Urological Cancer Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Urological Cancer Drugs Industry Development
Table Global Urological Cancer Drugs Sales Volume by Player (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Share by Player (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Share by Player in 2021
Table Urological Cancer Drugs Revenue (Million USD) by Player (2017-2022)
Table Urological Cancer Drugs Revenue Market Share by Player (2017-2022)
Table Urological Cancer Drugs Price by Player (2017-2022)
Table Urological Cancer Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Urological Cancer Drugs Sales Volume, Region Wise (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Urological Cancer Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Urological Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share, Region Wise in 2021
Table Global Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Urological Cancer Drugs Sales Volume by Type (2017-2022)
Table Global Urological Cancer Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume Market Share by Type in 2021
Table Global Urological Cancer Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Urological Cancer Drugs Revenue Market Share by Type (2017-2022)
Figure Global Urological Cancer Drugs Revenue Market Share by Type in 2021
Table Urological Cancer Drugs Price by Type (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Inlyta (Axitinib) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Opdivo (Nivolumab) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2017-2022)
Table Global Urological Cancer Drugs Consumption by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Market Share by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Prostate Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Bladder Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Kidney Cancer (2017-2022)
Table Global Urological Cancer Drugs Consumption and Growth Rate of Testicular Cancer (2017-2022)
Figure Global Urological Cancer Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Urological Cancer Drugs Price and Trend Forecast (2022-2027)
Figure USA Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Urological Cancer Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Urological Cancer Drugs Market Sales Volume Forecast, by Type
Table Global Urological Cancer Drugs Sales Volume Market Share Forecast, by Type
Table Global Urological Cancer Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Urological Cancer Drugs Revenue Market Share Forecast, by Type
Table Global Urological Cancer Drugs Price Forecast, by Type
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xofigo (Radium Ra 223 Dichloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Jevtana (Cabazitaxel) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Inlyta (Axitinib) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Votrient (Pazopanib Hydrochloride) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Sutent (Sunitinib Malate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Zytiga (Abiraterone Acetate) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Xtandi (Enzalutamide) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Opdivo (Nivolumab) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
Figure Global Urological Cancer Drugs Revenue (Million USD) and Growth Rate of Provenge (Sipuleucel-T) (2022-2027)
Table Global Urological Cancer Drugs Market Consumption Forecast, by Application
Table Global Urological Cancer Drugs Consumption Market Share Forecast, by Application
Table Global Urological Cancer Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Urological Cancer Drugs Revenue Market Share Forecast, by Application
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Prostate Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Bladder Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Kidney Cancer (2022-2027)
Figure Global Urological Cancer Drugs Consumption Value (Million USD) and Growth Rate of Testicular Cancer (2022-2027)
Figure Urological Cancer Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Celgene Corporation Profile
Table Celgene Corporation Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Celgene Corporation Urological Cancer Drugs Sales Volume and Growth Rate
Figure Celgene Corporation Revenue (Million USD) Market Share 2017-2022
Table GlaxoSmithKline Profile
Table GlaxoSmithKline Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure GlaxoSmithKline Urological Cancer Drugs Sales Volume and Growth Rate
Figure GlaxoSmithKline Revenue (Million USD) Market Share 2017-2022
Table Roche Healthcare Profile
Table Roche Healthcare Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Roche Healthcare Urological Cancer Drugs Sales Volume and Growth Rate
Figure Roche Healthcare Revenue (Million USD) Market Share 2017-2022
Table Ipsen Profile
Table Ipsen Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ipsen Urological Cancer Drugs Sales Volume and Growth Rate
Figure Ipsen Revenue (Million USD) Market Share 2017-2022
Table Ferring Pharmaceuticals Profile
Table Ferring Pharmaceuticals Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ferring Pharmaceuticals Urological Cancer Drugs Sales Volume and Growth Rate
Figure Ferring Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table Abbott Laboratories Profile
Table Abbott Laboratories Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Laboratories Urological Cancer Drugs Sales Volume and Growth Rate
Figure Abbott Laboratories Revenue (Million USD) Market Share 2017-2022
Table Indevus Pharmaceuticals Inc Profile
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales Volume and Growth Rate
Figure Indevus Pharmaceuticals Inc Revenue (Million USD) Market Share 2017-2022
Table Pfizer Profile
Table Pfizer Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pfizer Urological Cancer Drugs Sales Volume and Growth Rate
Figure Pfizer Revenue (Million USD) Market Share 2017-2022
Table Dendreon Corporation Profile
Table Dendreon Corporation Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Dendreon Corporation Urological Cancer Drugs Sales Volume and Growth Rate
Figure Dendreon Corporation Revenue (Million USD) Market Share 2017-2022
Table Sanofi S.A. Profile
Table Sanofi S.A. Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Sanofi S.A. Urological Cancer Drugs Sales Volume and Growth Rate
Figure Sanofi S.A. Revenue (Million USD) Market Share 2017-2022
Table AstraZeneca Profile
Table AstraZeneca Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure AstraZeneca Urological Cancer Drugs Sales Volume and Growth Rate
Figure AstraZeneca Revenue (Million USD) Market Share 2017-2022
Table Astellas Profile
Table Astellas Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Astellas Urological Cancer Drugs Sales Volume and Growth Rate
Figure Astellas Revenue (Million USD) Market Share 2017-2022
Table Novartis Profile
Table Novartis Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Novartis Urological Cancer Drugs Sales Volume and Growth Rate
Figure Novartis Revenue (Million USD) Market Share 2017-2022
Table Tolmar Inc Profile
Table Tolmar Inc Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Tolmar Inc Urological Cancer Drugs Sales Volume and Growth Rate
Figure Tolmar Inc Revenue (Million USD) Market Share 2017-2022
Table Johnson & Johnson Profile
Table Johnson & Johnson Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Johnson & Johnson Urological Cancer Drugs Sales Volume and Growth Rate
Figure Johnson & Johnson Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Urological Cancer Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Urological Cancer Drugs Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
